Functionality and health-status benefits associated with reduction of osteoarthritis pain

References

• Pleis JR, Lethbridge-Çejku M. Summary health statistics for U.S. adults: National health interview survey, 2005 (Available at: http://www.cdc.gov/nchs/data/series/sr_10/sr10_232.pdf). Vital Health Stat 2006;10
   Google Scholar
• Salaffi F, Carotti M, Stancati A, et al. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res 2005;17:255–63
   PubMed Web of Science ®Google Scholar
• Saltzman CL, Zimmerman MB, O’Rourke M, et al. Impact of comorbidities on the measurement of health in patients with ankle osteoarthritis. J Bone Joint Surg Am 2006;88:2366–72
   Google Scholar
• van der Waal JM, Terwee CB, van der Windt DA, et al. Health-related and overall quality of life of patients with chronic hip and knee complaints in general practice. Qual Life Res 2005;14:795–803
   PubMed Web of Science ®Google Scholar
• Rabenda V, Manette C, Lemmens R, et al. Prevalence and impact of osteoarthritis and osteoporosis on health-related quality of life among active subjects. Aging Clin Exp Res 2007;19:55–60
   PubMed Web of Science ®Google Scholar
• Gupta S, Hawker GA, Laporte A, et al. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford) 2005;44:1531–7
   PubMed Web of Science ®Google Scholar
• Ethgen O, Kahler KH, Kong SX, et al. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. J Rheumatol 2002;29:1147–55
   PubMed Web of Science ®Google Scholar
• Kosinski M, Janagap C, Gajria K, et al. Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis. Curr Med Res Opin 2007;23:1615–26
   PubMed Web of Science ®Google Scholar
• Gana TJ, Pascual MLG, Fleming RRB, et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006;22:1391–401
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9–19
   PubMed Web of Science ®Google Scholar
• Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833–40
   PubMed Web of Science ®Google Scholar
• Bellamy N. WOMAC Osteoarthritis Index: User Guide IV. Queensland, Australia: WOMAC, 2000
   Google Scholar
• McHorney CA, Ware JE, Jr., Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31: 247–63
   Google Scholar
• McHorney CA, Ware JE, Jr., Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32: 40–66
   Google Scholar
• Ware JE, Jr., Snow KK, Kosinski M, et al. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, 1993
   Google Scholar
• Ware JE, Jr., Kosinski M. SF-36 Physical & Mental Health Summary Scales: A Manual for Users of Version 1 (2nd Edition). Lincoln, RI: QualityMetric, 2001
   Google Scholar
• Kosinski M, Keller SD, Ware JE, Jr., et al. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999;37:MS23–39
   Google Scholar
• Kosinski M, Keller SD, Hatoum HT, et al. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care 1999;37:MS10–22
   Google Scholar
• Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain 2000;88:287–94
   PubMed Web of Science ®Google Scholar
• Farrar JT, Young JP, Jr., LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94: 149–58
   Google Scholar
• Tubach F, Ravaud P, Baron G, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005;64:29–33
   PubMed Web of Science ®Google Scholar
• Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59–71
   PubMed Web of Science ®Google Scholar
• Sharma L, Cahue S, Song J, et al. Physical functioning over three years in knee osteoarthritis: role of psychosocial, local mechanical, and neuromuscular factors. Arthritis Rheum 2003;48:3359–70
   PubMed Web of Science ®Google Scholar
• Ehrich EW, Davies GM, Watson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635–41
   PubMed Web of Science ®Google Scholar
• Bennett RM, Schein J, Kosinski MR, et al. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 2005;53:519–27
   PubMed Web of Science ®Google Scholar
• Kosinski MR, Schein JR, Vallow SM, et al. An observational study of health-related quality of life and pain outcomes in chronic low back pain patients treated with fentanyl transdermal system. Curr Med Res Opin 2005;21:849–62
   PubMed Web of Science ®Google Scholar
• Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996;66:229–37
   Google Scholar
• Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum 2001;45: 384–91
   Google Scholar
• Angst F, Aeschlimann A, Michel BA, et al. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol 2002;29:131–8
   PubMed Web of Science ®Google Scholar
• Escobar A, Quintana JM, Bilbao A, et al. Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage 2007;15:273–80
   PubMed Web of Science ®Google Scholar
• ULTRAM® ER (tramadol HCl) Extended-Release Tablets prescribing information. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc., 2006
   Google Scholar
• Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000;18:419–23
   PubMed Web of Science ®Google Scholar
• Kirwan JR. Minimum clinically important difference: the crock of gold at the end of the rainbow? J Rheumatol 2001;28:439–44
   PubMed Web of Science ®Google Scholar
• Quintana JM, Escobar A, Arostegui I, et al. Health-related quality of life and appropriateness of knee or hip joint replacement. Arch Intern Med 2006;166:220–6
   PubMed Web of Science ®Google Scholar